[Pubmed] Long-Term Cancer and Mortality After Thymectomy

Intégration des publications parues sur PUBMED
Répondre
Avatar du membre

Auteur du sujet
RSS-Bot
Ami(e) de Diamant
Ami(e) de Diamant
Messages : 6501
Enregistré le : 31 mai 2020 09:57
6
Zodiaque :
Âge : 22
Contact :
    Linux Chrome

[Pubmed] Long-Term Cancer and Mortality After Thymectomy

Message par RSS-Bot »


Eur J Neurol. 2026 Aug;33(8):e70721. doi: 10.1111/ene.70721.

ABSTRACT

BACKGROUND: Long-term health effects of thymectomy in adults remain uncertain. Previous reports suggested associations with increased mortality, cancer incidence, and autoimmune disease, although these findings may reflect differences in patient selection, surgical indication, or follow-up duration. We aimed to examine long-term outcomes following adult thymectomy.

METHODS: We performed a propensity score-matched retrospective study of patients who underwent thymectomy or comparator cardiothoracic procedures, with follow-up extending to 10 years. Primary outcomes were all-cause mortality, new-onset malignancy, and autoimmune disease. Findings were compared with those reported in a recent study that has raised caution regarding thymic excision.

RESULTS: We identified 425 patients who underwent thymectomy and 5401 controls who underwent coronary artery bypass or valve surgery. After matching, 398 patients remained in each group. Thymectomy was not associated with increased mortality at 5 years (HR = 0.63; 95% CI, 0.38-1.04) or 10 years (HR = 0.78; 95% CI, 0.54-1.13). Excluding reclassified thymic cancers, 5-year extrathymic malignancy incidence was 2.3% versus 1.8% (p = 0.54); no significant differences were observed in immune-related disease. Mortality was higher among patients with thymic malignancy. Among MG patients, only one event occurred, precluding reliable estimation.

CONCLUSIONS: Thymectomy was not associated with excess mortality or malignancy at 10 years compared with matched cardiothoracic controls. Indication-stratified analyses within the thymectomy cohort showed higher mortality for thymic malignancy, with insufficient events to assess outcomes in MG patients. These findings do not support a generalized survival penalty from thymectomy, though caution is warranted for incidental thymic removal.

PMID:42538851 | DOI:10.1111/ene.70721


Source: https://pubmed.ncbi.nlm.nih.gov/4253885 ... t5+40e1b98
Si vous appréciez notre travail, merci de nous soutenir un petit don en cliquant ICI

Pour obtenir la traduction en français,
cliquez sur le bouton situé dans la barre des menus en haut de cette page 

Image


Pour les donateurs, si cet article vous intéresse, nous pouvons faire l’acquisition d'un tiré-à-part.
Merci d'en faire la demande sur [email protected]


Bonne lecture...
Répondre

Retourner vers « Echos de la recherche »